Literature DB >> 9091884

[Report by the Scientific Working Group for Therapy of Lung Diseases: German Fibrosis Register with initial results].

H Schweisfurth.   

Abstract

The aim of this study was to evaluate the occurrence of interstitial lung diseases (ILD) in Germany. Therefore members of the WATL developed a questionnaire which was sent to pulmonary and other physicians who may encounter patients with ILD. In 1995 altogether 234 patients (105 males, 129 females, mean age 51 years, minimum 12, maximum 88 years) were referred to the registry. 126 of these patients were non-smoker, 58 ex-smoker, 45 smoker and in 5 patients no information was given. The following ILD were reported: sarcoidosis (n = 83, 36 males, 47 females), idiopathic pulmonary fibrosis (n = 76, 35 males, 41 females), idiopathic pulmonary fibrosis (n = 76, 35 males, 41 females), alveolitis (n = 31, 12 males, 19 females), bronchiolitis obliterans organizing pneumonia (n = 16, 6 males, 10 females) and others (n = 28, 16 males, 12 females). These preliminary data show that sarcoidosis (35%) and idiopathic fibrosis (33%) were the most frequently registered ILD.

Entities:  

Mesh:

Year:  1996        PMID: 9091884

Source DB:  PubMed          Journal:  Pneumologie        ISSN: 0934-8387


  12 in total

1.  Epidemiology of organising pneumonia in Iceland.

Authors:  G Gudmundsson; O Sveinsson; H J Isaksson; S Jonsson; H Frodadottir; T Aspelund
Journal:  Thorax       Date:  2006-06-29       Impact factor: 9.139

Review 2.  Type 2 macrophages and Th2 CD4+ cells in interstitial lung diseases (ILDs): an overview.

Authors:  Neftali Partida-Zavala; Marco Antonio Ponce-Gallegos; Ivette Buendía-Roldán; Ramcés Falfán-Valencia
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2018-04-28       Impact factor: 0.670

3.  Incidence of interstitial lung diseases in the south of Spain 1998-2000: the RENIA study.

Authors:  José Luis López-Campos; Eulogio Rodríguez-Becerra
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

4.  The incidence of interstitial lung disease 1995-2005: a Danish nationwide population-based study.

Authors:  Jette B Kornum; Steffen Christensen; Miriam Grijota; Lars Pedersen; Pia Wogelius; Annette Beiderbeck; Henrik Toft Sørensen
Journal:  BMC Pulm Med       Date:  2008-11-04       Impact factor: 3.317

5.  Spectrum of interstitial lung diseases at a tertiary center in a developing country: A study of 803 subjects.

Authors:  Sahajal Dhooria; Ritesh Agarwal; Inderpaul Singh Sehgal; Kuruswamy Thurai Prasad; Mandeep Garg; Amanjit Bal; Ashutosh Nath Aggarwal; Digambar Behera
Journal:  PLoS One       Date:  2018-02-08       Impact factor: 3.240

Review 6.  Interstitial Lung Diseases in Developing Countries.

Authors:  Pilar Rivera-Ortega; Maria Molina-Molina
Journal:  Ann Glob Health       Date:  2019-01-22       Impact factor: 2.462

Review 7.  The epidemiology of interstitial lung disease and its association with lung cancer.

Authors:  G Raghu; F Nyberg; G Morgan
Journal:  Br J Cancer       Date:  2004-08       Impact factor: 7.640

8.  Interstitial lung diseases in Saudi Arabia: A single-center study.

Authors:  Esam H Alhamad
Journal:  Ann Thorac Med       Date:  2013-01       Impact factor: 2.219

9.  Exploring Clinical and Epidemiological Characteristics of Interstitial Lung Diseases: Rationale, Aims, and Design of a Nationwide Prospective Registry--The EXCITING-ILD Registry.

Authors:  Michael Kreuter; Felix J F Herth; Margarethe Wacker; Reiner Leidl; Andreas Hellmann; Michael Pfeifer; Jürgen Behr; Sabine Witt; Dagmar Kauschka; Marcus Mall; Andreas Günther; Philipp Markart
Journal:  Biomed Res Int       Date:  2015-11-10       Impact factor: 3.411

10.  Diagnosis of Hypersensitivity Pneumonitis in Adults. An Official ATS/JRS/ALAT Clinical Practice Guideline.

Authors:  Ganesh Raghu; Martine Remy-Jardin; Christopher J Ryerson; Jeffrey L Myers; Michael Kreuter; Martina Vasakova; Elena Bargagli; Jonathan H Chung; Bridget F Collins; Elisabeth Bendstrup; Hassan A Chami; Abigail T Chua; Tamera J Corte; Jean-Charles Dalphin; Sonye K Danoff; Javier Diaz-Mendoza; Abhijit Duggal; Ryoko Egashira; Thomas Ewing; Mridu Gulati; Yoshikazu Inoue; Alex R Jenkins; Kerri A Johannson; Takeshi Johkoh; Maximiliano Tamae-Kakazu; Masanori Kitaichi; Shandra L Knight; Dirk Koschel; David J Lederer; Yolanda Mageto; Lisa A Maier; Carlos Matiz; Ferran Morell; Andrew G Nicholson; Setu Patolia; Carlos A Pereira; Elisabetta A Renzoni; Margaret L Salisbury; Moises Selman; Simon L F Walsh; Wim A Wuyts; Kevin C Wilson
Journal:  Am J Respir Crit Care Med       Date:  2020-08-01       Impact factor: 30.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.